Salvus Wealth Management LLC Buys Shares of 2,478 UnitedHealth Group Incorporated $UNH

Salvus Wealth Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,478 shares of the healthcare conglomerate’s stock, valued at approximately $818,000.

Other large investors have also added to or reduced their stakes in the company. Sagard Holdings Management Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at $29,000. Foster Dykema Cabot & Partners LLC grew its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 34 shares during the period. 1248 Management LLC bought a new position in UnitedHealth Group in the third quarter valued at about $29,000. Holos Integrated Wealth LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $29,000. Finally, Hurley Capital LLC lifted its stake in shares of UnitedHealth Group by 81.6% in the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 40 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on UNH. Leerink Partners reduced their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Truist Financial decreased their target price on UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Oppenheimer reduced their price target on UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Finally, Jefferies Financial Group lowered their price objective on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $372.13.

UnitedHealth Group Trading Down 0.7%

Shares of UNH stock opened at $270.48 on Thursday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. The stock has a fifty day simple moving average of $293.25 and a two-hundred day simple moving average of $323.43. The firm has a market capitalization of $245.51 billion, a PE ratio of 20.51, a PEG ratio of 1.25 and a beta of 0.41. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a dividend yield of 3.3%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 67.02%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH is expanding AI investments to drive efficiency and margin improvement; management reiterated growth and operational-improvement priorities at conferences, which supports medium-term profitability. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
• Positive Sentiment: Recent quarterly results showed a small EPS beat and revenue growth year-over-year; that underlying earnings strength and management’s reiterated guidance provide a constructive earnings foundation (supports analyst valuation).
• Neutral Sentiment: Wall Street analysts remain broadly bullish on UNH (average brokerage recommendation favors buying), which can prop up the stock, though the coverage is noted as often optimistic and may have limited immediate impact. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Industry hiring and AI-focused vendor moves (e.g., executive hiring at an AI-driven claims remediation firm) highlight sector innovation trends that could indirectly benefit large payor/Optum capabilities, but impact on UNH’s near-term stock trajectory is unclear. Andrew Harris Joins Red Sky Health as Senior Vice President of Operations
• Negative Sentiment: The DOJ has intensified an antitrust probe into Optum and UnitedHealth’s integrated model; heightened regulatory scrutiny raises headline risk, potential remedies, and valuation uncertainty for UNH. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
• Negative Sentiment: A proposed settlement in an insulin pricing case would leave CVS Caremark settled while UnitedHealth remains the sole holdout, underscoring litigation and competitive risks that could lead to future costs or reputational impacts if UNH becomes a target. CVS, FTC reach proposed settlement in insulin pricing case

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.